Wolverine Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $933K | Buy |
38,411
+15,032
| +64% | +$365K | ﹤0.01% | 440 |
|
|
2025
Q1 | $504K | Buy |
23,379
+9,745
| +71% | +$210K | ﹤0.01% | 675 |
|
|
2024
Q4 | $323K | Sell |
13,634
-34,872
| -72% | -$827K | ﹤0.01% | 1022 |
|
|
2024
Q3 | $1.24M | Sell |
48,506
-53,639
| -53% | -$1.37M | ﹤0.01% | 348 |
|
|
2024
Q2 | $2.4M | Buy |
102,145
+1,416
| +1% | +$33.2K | ﹤0.01% | 211 |
|
|
2024
Q1 | $2.9M | Buy |
100,729
+60,771
| +152% | +$1.75M | ﹤0.01% | 175 |
|
|
2023
Q4 | $1.31M | Buy |
39,958
+4,724
| +13% | +$155K | ﹤0.01% | 354 |
|
|
2023
Q3 | $982K | Buy |
35,234
+12,182
| +53% | +$339K | ﹤0.01% | 356 |
|
|
2023
Q2 | $777K | Buy |
23,052
+14,896
| +183% | +$502K | ﹤0.01% | 402 |
|
|
2023
Q1 | $234K | Sell |
8,156
-9,074
| -53% | -$260K | ﹤0.01% | 772 |
|
|
2022
Q4 | $486K | Sell |
17,230
-415
| -2% | -$11.7K | ﹤0.01% | 470 |
|
|
2022
Q3 | $580K | Buy |
17,645
+8,157
| +86% | +$268K | ﹤0.01% | 486 |
|
|
2022
Q2 | $305K | Buy |
+9,488
| New | +$305K | ﹤0.01% | 714 |
|
|
2022
Q1 | – | Sell |
-6,586
| Closed | -$410K | – | 1554 |
|
|
2021
Q4 | $410K | Buy |
6,586
+867
| +15% | +$54K | ﹤0.01% | 955 |
|
|
2021
Q3 | $422K | Buy |
+5,719
| New | +$422K | ﹤0.01% | 1099 |
|
|
2021
Q2 | – | Sell |
-5,343
| Closed | -$451K | – | 1833 |
|
|
2021
Q1 | $451K | Buy |
+5,343
| New | +$451K | ﹤0.01% | 1019 |
|
|
2020
Q4 | – | Sell |
-19,526
| Closed | -$1.25M | – | 1481 |
|
|
2020
Q3 | $1.25M | Buy |
19,526
+12,379
| +173% | +$795K | ﹤0.01% | 344 |
|
|
2020
Q2 | $364K | Buy |
+7,147
| New | +$364K | ﹤0.01% | 734 |
|